Skip to content
PubMed This is a summary of 75 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 75 referenced papers

Top Authors

Wenbin Shen
Capital Medical University
Mi Jin Kim
Samsung Medical Center
Yiyoung Kwon
Samsung Medical Center
Jie Wu
Capital Medical University
Michio Ozeki
Gifu University
Ahmet Oguzhan Ozen
Marmara University
Stephane Vignes
Hôpital Broussais
Rengui Wang
Capital Medical University
Ying Huang
Children's Hospital of Fudan University
Béatrice Dubern
Sorbonne Université

Top Institutions

Ranked by publications Top 10 institutions
01

Capital Medical University

Beijing, China

10 papers
02

Beijing Shijitan Hospital

Beijing, China

5 papers
05

Assistance Publique – Hôpitaux de Paris

Paris, France

4 papers
07

Niigata University

Niigata, Japan

3 papers
08

Hôpital Broussais

Paris, France

3 papers
Contributors Stephane Vignes
09

Children's Hospital of Fudan University

Shanghai, China

2 papers
10

Sorbonne Université

Paris, France

2 papers

References

References (75)
  1. 1

    [Protein-losing enteropathy].

    Amiot A

    La Revue de medecine interne 2015; (36(7)):467-73.

    PMID: 25618488
  2. 2

    A novel CCBE1 mutation leading to a mild form of hennekam syndrome: case report and review of the literature.

    Frosk P, Chodirker B, Simard L, et al.

    BMC medical genetics 2015; (16()):28 doi:10.1186/s12881-015-0175-0.

    PMID: 25925991
  3. 3

    Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC).

    Pollack SF, Geffrey AL, Thiele EA, Shah U

    American journal of medical genetics. Part A 2015; (167A(9)):2209-12 doi:10.1002/ajmg.a.37148.

    PMID: 25943403
  4. 4

    Surgical therapy of primary intestinal lymphangiectasia in adults.

    Huber T, Paschold M, Eckardt AJ, et al.

    Journal of surgical case reports 2015; (2015(7)).

    PMID: 26169531
  5. 5

    Primary intestinal lymphangiectasia with generalized warts.

    Lee SJ, Song HJ, Boo SJ, et al.

    World journal of gastroenterology 2015; (21(27)):8467-72 doi:10.3748/wjg.v21.i27.8467.

    PMID: 26217101
  6. 6

    Severe Refractory Anemia in Primary Intestinal Lymphangiectasia. A Case Report.

    Balaban VD, Popp A, Grasu M, et al.

    Journal of gastrointestinal and liver diseases : JGLD 2015; (24(3)):369-73 doi:10.15403/jgld.2014.1121.243.bal.

    PMID: 26405709
  7. 7

    Intestinal lymphangiectasia in children. A favorable response to dietary modifications.

    Isa HM, Al-Arayedh GG, Mohamed AM

    Saudi medical journal 2016; (37(2)):199-204 doi:10.15537/smj.2016.2.13232.

    PMID: 26837404
  8. 8

    Secondary hypogammaglobulinemia in Waldmann's disease treated with subcutaneous immunoglobulins.

    Patuzzo G, Tinazzi E, Micheletti M, et al.

    European annals of allergy and clinical immunology 2016; (48(2)):55-7.

    PMID: 26934740
  9. 9

    Primary Intestinal Lymphangiectasia Manifested as Unusual Edemas and Effusions: A Case Report.

    Wang X, Jin H, Wu W

    Medicine 2016; (95(10)):e2849 doi:10.1097/MD.0000000000002849.

    PMID: 26962779
  10. 10

    Primary intestinal lymphangiectasia: Multiple detector computed tomography findings after direct lymphangiography.

    Sun X, Shen W, Chen X, et al.

    Journal of medical imaging and radiation oncology 2017; (61(5)):607-613 doi:10.1111/1754-9485.12606.

    PMID: 28345300
  11. 11

    Lymphatic deletion of calcitonin receptor-like receptor exacerbates intestinal inflammation.

    Davis RB, Kechele DO, Blakeney ES, et al.

    JCI insight 2017; (2(6)):e92465.

    PMID: 28352669
  12. 12

    Waldmann's disease: a rare cause of protein losing enteropathy in an adult patient.

    Martins CR, Gagnaire A, Rostain F, Lepage C

    Revista espanola de enfermedades digestivas 2017; (109(5)):385-388 doi:10.17235/reed.2017.4593/2016.

    PMID: 28376626
  13. 13

    Waldmann's Disease (Primary Intestinal Lymphangiectasia) with Atrial Septal Defect.

    Aroor S, Mundkur S, Kanaparthi S, Kumar S

    Journal of clinical and diagnostic research : JCDR 2017; (11(4)):SD03-SD04 doi:10.7860/JCDR/2017/24989.9742.

    PMID: 28571224
  14. 14

    CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.

    Ozen A, Comrie WA, Ardy RC, et al.

    The New England journal of medicine 2017; (377(1)):52-61 doi:10.1056/NEJMoa1615887.

    PMID: 28657829
  15. 15

    Dachsous1-Fat4 Signaling Controls Endothelial Cell Polarization During Lymphatic Valve Morphogenesis-Brief Report.

    Pujol F, Hodgson T, Martinez-Corral I, et al.

    Arteriosclerosis, thrombosis, and vascular biology 2017; (37(9)):1732-1735 doi:10.1161/ATVBAHA.117.309818.

    PMID: 28705793
  16. 16

    Primary intestinal lymphangiectasia in an elderly female patient: A case report on a rare cause of secondary immunodeficiency.

    Huber X, Degen L, Muenst S, Trendelenburg M

    Medicine 2017; (96(31)):e7729 doi:10.1097/MD.0000000000007729.

    PMID: 28767614
  17. 17

    Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract.

    Baluk P, Yao LC, Flores JC, et al.

    JCI insight 2017; (2(16)).

    PMID: 28814666
  18. 18

    [Primary intestinal lymphangiectasia (Waldmann's disease)].

    Vignes S, Bellanger J

    La Revue de medecine interne 2018; (39(7)):580-585 doi:10.1016/j.revmed.2017.07.009.

    PMID: 28867533
  19. 19

    Loss of ADAMTS3 activity causes Hennekam lymphangiectasia-lymphedema syndrome 3.

    Brouillard P, Dupont L, Helaers R, et al.

    Human molecular genetics 2017; (26(21)):4095-4104 doi:10.1093/hmg/ddx297.

    PMID: 28985353
  20. 20

    Case report of primary intestinal lymphangiectasia diagnosed in an octogenarian by ileal intubation and by push enteroscopy after missed diagnosis by standard colonoscopy and EGD.

    Cappell MS, Edhi A, Amin M

    Medicine 2018; (97(3)):e9649 doi:10.1097/MD.0000000000009649.

    PMID: 29505002
  21. 21

    Van Maldergem syndrome and Hennekam syndrome: Further delineation of allelic phenotypes.

    Ivanovski I, Akbaroghli S, Pollazzon M, et al.

    American journal of medical genetics. Part A 2018; (176(5)):1166-1174 doi:10.1002/ajmg.a.38652.

    PMID: 29681106
  22. 22

    Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.

    Kurolap A, Eshach Adiv O, Hershkovitz T, et al.

    Journal of pediatric gastroenterology and nutrition 2019; (68(3)):325-333 doi:10.1097/MPG.0000000000002198.

    PMID: 30418410
  23. 23

    Milky Mesentery: Acute Abdomen with Chylous Ascites.

    Goel A, Gaur MK, Garg PK

    Indian pediatrics 2018; (55(10)):909-910.

    PMID: 30426960
  24. 24

    An additional case of Hennekam lymphangiectasia-lymphedema syndrome caused by loss-of-function mutation in ADAMTS3.

    Scheuerle AE, Sweed NT, Timmons CF, et al.

    American journal of medical genetics. Part A 2018; (176(12)):2858-2861 doi:10.1002/ajmg.a.40633.

    PMID: 30450763
  25. 25

    Novel Magnified Single-Balloon Enteroscopy Enables Observation of Jejunal White Spots Associated with Lymphangiectasia.

    Tominaga K, Tsuchiya A, Kawata Y, et al.

    Digestive diseases (Basel, Switzerland) 2019; (37(2)):170-174 doi:10.1159/000493578.

    PMID: 30466073
  26. 26

    CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease.

    Ozen A

    Immunological reviews 2019; (287(1)):20-32 doi:10.1111/imr.12715.

    PMID: 30565236
  27. 27

    Pediatric localized intestinal lymphangiectasia treated with resection.

    Mari J, Kovacs T, Pasztor G, et al.

    International medical case reports journal 2019; (12()):23-27 doi:10.2147/IMCRJ.S192940.

    PMID: 30804688
  28. 28

    Phenotype and Genotype of a Cohort of Chinese Children with Early-Onset Protein-Losing Enteropathy.

    Ye Z, Huang Y, Wang Y, et al.

    The Journal of pediatrics 2019; (208()):38-42.e3 doi:10.1016/j.jpeds.2018.12.003.

    PMID: 30853196
  29. 29

    Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia.

    Prasad D, Srivastava A, Tambe A, et al.

    Digestive diseases (Basel, Switzerland) 2019; (37(6)):458-466 doi:10.1159/000499450.

    PMID: 31030202
  30. 30

    Generalized Lymphatic Anomaly and Gorham-Stout Disease: Overview and Recent Insights.

    Ozeki M, Fukao T

    Advances in wound care 2019; (8(6)):230-245 doi:10.1089/wound.2018.0850.

    PMID: 31236308
  31. 31

    Updates on bone health in children with gastrointestinal diseases.

    Yang HR

    Annals of pediatric endocrinology & metabolism 2020; (25(1)):10-14 doi:10.6065/apem.2020.25.1.10.

    PMID: 32252211
  32. 32

    Tuberous sclerosis complex presenting as primary intestinal lymphangiectasia: A case report.

    Lin WH, Zhang ZH, Wang HL, et al.

    World journal of clinical cases 2020; (8(10)):1995-2000 doi:10.12998/wjcc.v8.i10.1995.

    PMID: 32518792
  33. 33

    Primary intestinal lymphangiectasia diagnosed by video capsule endoscopy in a patient with immunodeficiency presenting with Morganella morganii bacteraemia.

    Cunningham JM, Nepal S, Truesdale AE

    BMJ case reports 2020; (13(9)) doi:10.1136/bcr-2020-235898.

    PMID: 32928820
  34. 34

    Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature.

    Kwon Y, Kim ES, Choe YH, Kim MJ

    BMC pediatrics 2021; (21(1)):21 doi:10.1186/s12887-020-02447-5.

    PMID: 33407260
  35. 35

    Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature.

    Huber R, Semmler G, Mayr A, et al.

    World journal of gastroenterology 2020; (26(48)):7707-7718 doi:10.3748/wjg.v26.i48.7707.

    PMID: 33505146
  36. 36

    The diagnostic value of capsule endoscopy in children with intestinal lymphangiectasia.

    Wu J, Huang Z, Ji M, et al.

    Revista espanola de enfermedades digestivas 2021; (113(11)):765-769 doi:10.17235/reed.2021.7682/2020.

    PMID: 33733798
  37. 37

    Refractory primary intestinal lymphangiectasia effectively managed with subcutaneous octreotide.

    Halim A, Youd P, Thorpe J, Halim I

    BMJ case reports 2021; (14(4)) doi:10.1136/bcr-2020-238457.

    PMID: 33837021
  38. 38

    Therapeutic Lymphatic Embolization in Pediatric Primary Intestinal Lymphangiectasia.

    Kwon Y, Kim ES, Choe YH, et al.

    Yonsei medical journal 2021; (62(5)):470-473 doi:10.3349/ymj.2021.62.5.470.

    PMID: 33908219
  39. 39

    Primary intestinal lymphangiectasia presenting as limb hemihyperplasia: a case report and literature review.

    Khayat AA

    BMC gastroenterology 2021; (21(1)):225 doi:10.1186/s12876-021-01813-6.

    PMID: 34006223
  40. 40

    Home parenteral nutrition a life-saving therapy in a primary intestinal lymphangiectasia patient affecting the entire GI tract - 3 year follow-up case report.

    Mańkowska-Wierzbicka D, Kloska M, Karwowska K, et al.

    Annals of medicine and surgery (2012) 2021; (67()):102483 doi:10.1016/j.amsu.2021.102483.

    PMID: 34168874
  41. 41

    An unusual cause of heparin resistance - A case report.

    Raja J, Baruah SD, Santhosh V, et al.

    Annals of cardiac anaesthesia 2021; (24(3)):375-377 doi:10.4103/aca.ACA_197_19.

    PMID: 34269273
  42. 42

    Complicated primary intestinal lymphangiectasia (Waldmann's disease) in a child successfully treated with octreotide: A case report from a low-resource setting.

    El Haddar Z, Sbia Y, Rkain M, et al.

    Annals of medicine and surgery (2012) 2021; (68()):102588 doi:10.1016/j.amsu.2021.102588.

    PMID: 34401115
  43. 43

    The Update of Treatment for Primary Intestinal Lymphangiectasia.

    Kwon Y, Kim MJ

    Pediatric gastroenterology, hepatology & nutrition 2021; (24(5)):413-422 doi:10.5223/pghn.2021.24.5.413.

    PMID: 34557394
  44. 44

    Primary intestinal lymphangiectasia in children: Twelve years of experience in the diagnosis and management.

    Niu Y, Wu Q, Wang Y, et al.

    Asia Pacific journal of clinical nutrition 2021; (30(3)):358-364 doi:10.6133/apjcn.202109_30(3).0002.

    PMID: 34587695
  45. 45

    A case of primary intestinal lymphangiectasia with non-Hodgkin lymphoma.

    Hu D, Cui X, Ren W, et al.

    BMC gastroenterology 2021; (21(1)):461 doi:10.1186/s12876-021-01997-x.

    PMID: 34895151
  46. 46

    Primary intestinal lymphangiectasia: a rare disease as a cause of protein-losing enteropathy.

    González Núñez R, Domínguez Carbajo AB, Alcoba Vega L, et al.

    Revista espanola de enfermedades digestivas 2022; (114(12)):762-763 doi:10.17235/reed.2022.8673/2022.

    PMID: 35240852
  47. 47

    Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature.

    Feng H, Zou L, Zhai X, et al.

    BMC gastroenterology 2022; (22(1)):246 doi:10.1186/s12876-022-02318-6.

    PMID: 35570283
  48. 48

    [CD5-positive diffuse large B-cell lymphoma with gastrointestinal infiltration presenting with protein-losing enteropathy].

    Nakayama A, Sakai K, Fujioka Y, et al.

    [Rinsho ketsueki] The Japanese journal of clinical hematology 2022; (63(6)):530-535 doi:10.11406/rinketsu.63.530.

    PMID: 35831184
  49. 49

    Endoscopic classification and pathological features of primary intestinal lymphangiectasia.

    Meng MM, Liu KL, Xue XY, et al.

    World journal of gastroenterology 2022; (28(22)):2482-2493 doi:10.3748/wjg.v28.i22.2482.

    PMID: 35979262
  50. 50

    Correlation between capsule endoscopy classification and CT lymphangiography of primary intestinal lymphangiectasia.

    Zhao Q, Sun X, Liu K, et al.

    Clinical radiology 2023; (78(3)):219-226 doi:10.1016/j.crad.2022.10.001.

    PMID: 36509551
  51. 51

    Adult-Onset Primary Intestinal Lymphangiectasia With Liver Enzymes Elevation.

    Nguyen CD, Buchman A, Bui HH, et al.

    ACG case reports journal 2022; (9(12)):e00939 doi:10.14309/crj.0000000000000939.

    PMID: 36600788
  52. 52

    Polypoid Lymphangiectasia in the Sigmoid Colon: A Case Report of a Rare Entity.

    Alshaakh Moh'D Mari A, Varshney A, Recker K, et al.

    Cureus 2023; (15(6)):e40632 doi:10.7759/cureus.40632.

    PMID: 37476133
  53. 53

    Small intestinal mucosal abnormalities using video capsule endoscopy in intestinal lymphangiectasia.

    Lin L, Liu K, Liu H, et al.

    Orphanet journal of rare diseases 2023; (18(1)):308 doi:10.1186/s13023-023-02914-z.

    PMID: 37784188
  54. 54

    Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial.

    Ozeki M, Endo S, Yasue S, et al.

    Frontiers in medicine 2024; (11()):1335469 doi:10.3389/fmed.2024.1335469.

    PMID: 38390569
  55. 55

    Hypocalcaemic tetany linked to vitamin D deficiency and hypomagnesemia in primary intestinal lymphangiectasia: a literature review.

    Thapaliya I, Yadav J

    Annals of medicine and surgery (2012) 2024; (86(4)):2049-2057 doi:10.1097/MS9.0000000000001850.

    PMID: 38576918
  56. 56

    Comprehensive nutrition guidelines and management strategies for enteropathy in children.

    Savoca ML, Brownell JN

    Seminars in pediatric surgery 2024; (33(3)):151425 doi:10.1016/j.sempedsurg.2024.151425.

    PMID: 38849288
  57. 57

    Intestinal lymphangiectasia: Understanding the bigger picture.

    Marrapu S, Kumar R

    World journal of clinical cases 2024; (12(18)):3298-3303 doi:10.12998/wjcc.v12.i18.3298.

    PMID: 38983414
  58. 58

    Protein-losing enteropathy as a result of colon polyposis and colon cancer: a multidisciplinary approach to diagnosis and treatment.

    Kuipers H, van Westreenen HL, Moll FCP, de Vos Tot Nederveen Cappel WH

    BMJ case reports 2024; (17(8)) doi:10.1136/bcr-2024-261081.

    PMID: 39159982
  59. 59

    Endoscopic Diagnosis of Primary Intestinal Lymphangiectasia in an Adult With Refractory Protein-Losing Enteropathy: A Case Report.

    Khalil Z, Ali HN, Ibrahim H, Al-Abbedien EZ

    Cureus 2024; (16(8)):e66141 doi:10.7759/cureus.66141.

    PMID: 39233993
  60. 60

    Constrictive Pericarditis and Protein-Losing Enteropathies: Exploring the Heart-Gut Axis.

    Birtolo LI, Shahini E

    Journal of clinical medicine 2024; (13(17)) doi:10.3390/jcm13175150.

    PMID: 39274362
  61. 61

    Elderly Onset Primary Intestinal Lymphangiectasia-A Rare Case.

    Goh LH, Manoharan M, Goh KL

    JGH open : an open access journal of gastroenterology and hepatology 2025; (9(1)):e70102 doi:10.1002/jgh3.70102.

    PMID: 39850090
  62. 62

    Complement dysregulation at lymphatics.

    Ozen A, Can S, Sefer AP, et al.

    The Journal of allergy and clinical immunology 2025; (156(2)):205-214 doi:10.1016/j.jaci.2025.04.020.

    PMID: 40300720
  63. 63

    Secondary Hyperparathyroidism in Primary Intestinal Lymphangiectasia: A Report of Four Cases.

    Zhang DX, Hao K, Zhang L, et al.

    Gastroenterology research 2025; (18(3)):152-158 doi:10.14740/gr2022.

    PMID: 40503188
  64. 64

    Protein-losing enteropathy and multiple vasculature dysplasia in LZTR1-related Noonan syndrome: A case report and review of literature.

    Tian QJ, Zhang LJ, Zhang Q, et al.

    World journal of gastroenterology 2025; (31(17)):105347 doi:10.3748/wjg.v31.i17.105347.

    PMID: 40521264
  65. 65

    Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

    Vignes S, Uzzan M, Arrivé L, et al.

    Orphanet journal of rare diseases 2025; (20(1)):356 doi:10.1186/s13023-025-03657-9.

    PMID: 40640921
  66. 66

    An unusual etiology of diarrhea: primary intestinal lymphangiectasia.

    Dai C, Huang YH

    Revista espanola de enfermedades digestivas 2026; (118(2)):118-119 doi:10.17235/reed.2025.11483/2025.

    PMID: 40737280
  67. 67

    Clinical characterization of primary intestinal lymphangiectasia in infants and young children: a single-center retrospective analysis in China.

    Li D, Zhang T, Ye X, et al.

    Translational pediatrics 2025; (14(8)):1896-1907 doi:10.21037/tp-2025-187.

    PMID: 40949899
  68. 68

    Clinical presentation, treatment, and outcome of children with primary intestinal lymphangiectasia: A national retrospective study.

    Goret N, Lambe C, Ecochard-Dugelay E, et al.

    Journal of pediatric gastroenterology and nutrition 2026; (82(2)):398-406 doi:10.1002/jpn3.70266.

    PMID: 41277165
  69. 69

    Biallelic Splicing Variant c.12479+3A>G in FAT4 Causes Hennekam Lymphangiectasia-Lymphedema Syndrome 2.

    Mascarenhas S, Gupta Y, K A A, et al.

    American journal of medical genetics. Part A 2026; (200(9)):2019-2024 doi:10.1002/ajmg.a.70166.

    PMID: 41992670
  70. 70

    Playing CATCH-up: a case report of profound protein-losing enteropathy and gastrointestinal haemorrhage from intestinal lymphangiectasia in DiGeorge syndrome.

    Carrigan L, Yap J, Cheung M

    European heart journal. Case reports 2026; (10(5)):ytag257 doi:10.1093/ehjcr/ytag257.

    PMID: 42125525
  71. 71

    Primary Intestinal Lymphangiectasia as a cause of secondary combined immunodeficiency: case study and literature review.

    Hall RM, Panton LA, Ineus L, et al.

    Clinical immunology communications 2026; (9()):133-137 doi:10.1016/j.clicom.2026.05.002.

    PMID: 42416886
  72. 72

    Protein-losing enteropathy in a child with hypoplastic left heart syndrome after Fontan palliation: a case report.

    Saife S, Saife S, Zetawi M

    Oxford medical case reports 2026; (2026(8)):omag145 doi:10.1093/omcr/omag145.

    PMID: 42549227
  73. 73

    Targeted complement inhibition with pozelimab in children with CD55 deficiency.

    Grotra R, Bhadani H, Malik R

    BMJ case reports 2026; (19(8)) doi:10.1136/bcr-2026-273991.

    PMID: 42608073
  74. 74

    Successful Early Therapy With Sirolimus for an Infant With Primary Intestinal Lymphangiectasia.

    Yamamoto S, Sugino Y, Yamashita T, et al.

    Case reports in pediatrics 2026; (2026()):7717714 doi:10.1155/crpe/7717714.

    PMID: 42751049
  75. 75

    Case Report: Six infants with primary intestinal lymphangiectasia: clinical manifestations of refractory cases and preliminary stratified clinical management experience.

    Shi M, Xue N, Tang Y, et al.

    Frontiers in pediatrics 2026; (14()):1949058 doi:10.3389/fped.2026.1949058.

    PMID: 42818768